289 related articles for article (PubMed ID: 11910026)
1. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues.
Crabb JW; O'Neil J; Miyagi M; West K; Hoff HF
Protein Sci; 2002 Apr; 11(4):831-40. PubMed ID: 11910026
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action.
Krohne TU; Kaemmerer E; Holz FG; Kopitz J
Exp Eye Res; 2010 Feb; 90(2):261-6. PubMed ID: 19895809
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins.
Aslebagh R; Pfeffer BA; Fliesler SJ; Darie CC
Electrophoresis; 2016 Oct; 37(20):2615-2623. PubMed ID: 27184861
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal.
Lee SH; Takahashi R; Goto T; Oe T
Chem Res Toxicol; 2010 Nov; 23(11):1771-85. PubMed ID: 20977208
[TBL] [Abstract][Full Text] [Related]
5. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase.
Ishii T; Tatsuda E; Kumazawa S; Nakayama T; Uchida K
Biochemistry; 2003 Apr; 42(12):3474-80. PubMed ID: 12653551
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme.
O'Neil J; Hoppe G; Sayre LM; Hoff HF
Free Radic Biol Med; 1997; 23(2):215-25. PubMed ID: 9199883
[TBL] [Abstract][Full Text] [Related]
8. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
9. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.
Carbone DL; Doorn JA; Kiebler Z; Petersen DR
Chem Res Toxicol; 2005 Aug; 18(8):1324-31. PubMed ID: 16097806
[TBL] [Abstract][Full Text] [Related]
10. Phospholipids in oxidized low density lipoproteins perturb the ability of macrophages to degrade internalized macromolecules and reduce intracellular cathepsin B activity.
O'Neil J; Hoppe G; Hoff HF
Atherosclerosis; 2003 Aug; 169(2):215-24. PubMed ID: 12921972
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical configuration of 4-hydroxy-2-nonenal-cysteine adducts and their stereoselective formation in a redox-regulated protein.
Wakita C; Maeshima T; Yamazaki A; Shibata T; Ito S; Akagawa M; Ojika M; Yodoi J; Uchida K
J Biol Chem; 2009 Oct; 284(42):28810-22. PubMed ID: 19692331
[TBL] [Abstract][Full Text] [Related]
12. 4-Hydroxy-2-nonenal-modified glyceraldehyde-3-phosphate dehydrogenase is degraded by cathepsin G.
Tsuchiya Y; Okuno Y; Hishinuma K; Ezaki A; Okada G; Yamaguchi M; Chikuma T; Hojo H
Free Radic Biol Med; 2007 Dec; 43(12):1604-15. PubMed ID: 18037126
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
14. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
15. Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle.
Aldini G; Granata P; Carini M
J Mass Spectrom; 2002 Dec; 37(12):1219-28. PubMed ID: 12489081
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.
Hoff HF; O'Neil J; Wu Z; Hoppe G; Salomon RL
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):275-82. PubMed ID: 12588771
[TBL] [Abstract][Full Text] [Related]
17. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart.
Chen J; Henderson GI; Freeman GL
J Mol Cell Cardiol; 2001 Nov; 33(11):1919-27. PubMed ID: 11708837
[TBL] [Abstract][Full Text] [Related]
18. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease.
Carbone DL; Doorn JA; Kiebler Z; Ickes BR; Petersen DR
J Pharmacol Exp Ther; 2005 Oct; 315(1):8-15. PubMed ID: 15951401
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal.
Aldini G; Gamberoni L; Orioli M; Beretta G; Regazzoni L; Maffei Facino R; Carini M
J Mass Spectrom; 2006 Sep; 41(9):1149-61. PubMed ID: 16888752
[TBL] [Abstract][Full Text] [Related]
20. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal.
Musatov A; Carroll CA; Liu YC; Henderson GI; Weintraub ST; Robinson NC
Biochemistry; 2002 Jun; 41(25):8212-20. PubMed ID: 12069614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
